Wiza logo
Wiza logo
Get a demo
Get started for free

Matt Pietras - Email & Phone Number

VP of Finance at Civi Biopharma, Inc.

Matt Pietras is based out of Washington DC-Baltimore Area and works at Civi Biopharma, Inc. as VP of Finance.

Matt Pietras's Contact Information

Matt Pietras's Personal email
m*****@gmai***.com
Valid
Latest update
October 10, 2025
Location
Washington DC-Baltimore Area

Matt's current employer

Civi Biopharma, Inc. logo

Civi Biopharma, Inc.

Description
HQ Location
Chevy Chase, Maryland, United States
Number of employees
11-50
Industry
Biotechnology Research
Latest update
May 1, 2024

Frequent questions about Matt Pietras

What company is Matt Pietras working for?
Matt Pietras works for Civi Biopharma, Inc..
What is Matt Pietras's function at Civi Biopharma, Inc.?
Matt Pietras is VP of Finance at Civi Biopharma, Inc..
Where is Matt Pietras based?
Matt Pietras is based out of Washington DC-Baltimore Area.
What is Matt Pietras's personal email address?
Matt Pietras's personal email address is m*****@gmai***.com
Who are Matt Pietras's co-workers?
Matt Pietras's colleagues are Shal Jacobovitz, Allison Widlitz, Christa-Lynn Vampola, Stewart Noble, Joel Gervasi, Henrik Ørum, Charles Shear.
Find anyone's contact info.
Get 20 free email reveals

Matt's co-workers

Shal Jacobovitz avatar
Shal Jacobovitz
CEO
Allison Widlitz avatar
Allison Widlitz
Vice President Medical Affairs
Christa-Lynn Vampola avatar
Christa-Lynn Vampola
VP, Regulatory and Clinical Science
Stewart Noble avatar
Stewart Noble
Vice President, Chemistry, Manufacturing & Controls
Joel Gervasi avatar
Joel Gervasi
Financial Controller
Henrik Ørum avatar
Henrik Ørum
Chief Scientific Officer
Charles Shear avatar
Charles Shear
Chief Development Officer
Wiza does not guarantee or claim any of the information found on this public directory to be 100% accurate or up to date.Information found here is gathered from a variety of online and offline sources.If you wish to exclude your personal data from this public directory please fill out the optout form.